Loading...
The Financial Express

Search results for: Health

Plasma treatment shows little benefit in severe COVID-19 cases

Plasma treatment shows little benefit in severe COVID-19 cases

Reuters 2020-11-26 17:22:15

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.   Plasma...

Mutations not making COVID-19 virus able to spread more rapidly: Study

Mutations not making COVID-19 virus able to spread more rapidly: Study

Reuters 2020-11-25 20:11:43

The COVID-19-causing coronavirus is mutating as it spreads around the world in the pandemic, but none of the mutations currently documented appears to be making it able to spread more rapidly, scienti...

Plasma therapy shows little benefit in Covid patients: Study

Plasma therapy shows little benefit in Covid patients: Study

-- 2020-11-25 12:27:31

Using blood plasma from Covid-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in...

WHO says world’s poorest must not be ‘trampled’ in Covid vaccine race

WHO says world’s poorest must not be ‘trampled’ in Covid vaccine race

-- 2020-11-24 13:09:36

The world's poorest and most vulnerable must not be "trampled in the stampede" for Covid-19 vaccines, the head of the World Health Organization has warned. Dr Tedros Adhanom Ghebreyesus said successf...

India’s Serum Institute says country first priority for vaccine delivery

India’s Serum Institute says country first priority for vaccine delivery

REUTERS 2020-11-24 12:10:10

The Serum Institute of India, the world's largest manufacturer of vaccines by volume, will first focus on supplying AstraZeneca Plc's COVID-19 vaccine to Indians before distributing it to other countr...

AstraZeneca, Oxford vaccine could be 90pc effective against coronavirus, results show

AstraZeneca, Oxford vaccine could be 90pc effective against coronavirus, results show

-- 2020-11-23 14:52:43

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90 per cent effective without any serious side effects, the latest drugmaker to unveil positive interim data in a scien...

Moderna to charge $25-$37 for each dose of Covid-19 vaccine

Moderna to charge $25-$37 for each dose of Covid-19 vaccine

-- 2020-11-22 10:37:47

Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (Wam...

Covid-19 reinfection unlikely for at least six months, study finds

Covid-19 reinfection unlikely for at least six months, study finds

-- 2020-11-20 20:54:29

People who’ve had Covid-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of th...

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US

AP 2020-11-20 18:19:58

Pfizer said Friday it is asking US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually...

WHO warns against use of remdesivir for hospitalised Covid patients

WHO warns against use of remdesivir for hospitalised Covid patients

REUTERS 2020-11-20 14:28:46

Gilead’s drug remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilat...

BioNTech hopeful of getting vaccine approval in mid-December

BioNTech hopeful of getting vaccine approval in mid-December

-- 2020-11-19 16:55:07

US and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of pos...

Pfizer vaccine reports 95pc efficacy in late-stage trial

Pfizer vaccine reports 95pc efficacy in late-stage trial

-- 2020-11-18 18:51:31

Pfizer Inc said on Wednesday that final results from the late-stage trial of its Covid-19 vaccine show it was 95 per cent effective, adding it had the required two-months of safety data and would appl...

No firm evidence of food trade spreading coronavirus, says FAO

No firm evidence of food trade spreading coronavirus, says FAO

Reuters 2020-11-18 17:55:02

There is no significant evidence of coronavirus being spread through food trade and such reports "need to be minimised", Maximo Torero Cullen, chief economist of the United Nations food and agricultur...

Sinovac's COVID-19 vaccine triggers quick immune response

Sinovac's COVID-19 vaccine triggers quick immune response

Reuters 2020-11-18 16:55:28

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac induced a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary...

Mouthwash can kill COVID-19 in 30 seconds: Study

Mouthwash can kill COVID-19 in 30 seconds: Study

-- 2020-11-17 19:54:17

Over-the-counter mouthwash can kill coronavirus within 30 seconds of exposure, a study has found, reports Aljazeera.com. Scientists at Cardiff University discovered mouthwash containing at least 0.07...

Pfizer piloting Covid-19 vaccine in four US states

Pfizer piloting Covid-19 vaccine in four US states

REUTERS 2020-11-17 10:25:56

Pfizer said on Monday (US standard time) it was starting a pilot programme for Covid-19 immunisation in four US states to help refine the plan for the delivery and deployment of its vaccine candidate....

J&J begins two-dose trial of its Covid vaccine candidate

J&J begins two-dose trial of its Covid vaccine candidate

REUTERS 2020-11-16 13:02:14

Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental Covid-19 vaccine and evaluate potential incremental benefits for the dur...

Big study supports cheap combo pill to lower heart risks

Big study supports cheap combo pill to lower heart risks

AP 2020-11-14 18:03:40

A daily pill combining four cholesterol and blood pressure medicines taken with low-dose aspirin cut the risk of heart attacks, strokes and heart-related deaths by nearly one third in a large internat...

Diabetic patients at increased risk of severe disease

Diabetic patients at increased risk of severe disease

-- 2020-11-14 16:41:22

Amid the number of people with diabetes surge, the UN Secretary-General António Guterres stressed need for strengthening health system as many diabetic patients are at “increased risk of...

Covid-19 fatality rate down 30pc since April

Covid-19 fatality rate down 30pc since April

-- 2020-11-13 16:37:02

The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the University of Washington’s Institute for Heal...

Ethnic minorities disproportionately impacted by Covid-19: The Lancet

Ethnic minorities disproportionately impacted by Covid-19: The Lancet

REUTERS 2020-11-13 14:05:34

Ethnic minority groups are disproportionately affected by the novel coronavirus, with Blacks and Asians at increased risk of Covid-19 infection compared to white individuals, according to an analysis...

Global measles cases hit 23-year high in 2019

Global measles cases hit 23-year high in 2019

FE ONLINE REPORT 2020-11-13 10:46:17

Measles surged worldwide in 2019 reaching highest number of reported cases in 23 years, according to a UNICEF statement issued on Friday. Highlighted in a publication by the World Health Organization...

Pneumonia kills 67 children every day in Bangladesh

Pneumonia kills 67 children every day in Bangladesh

-- 2020-11-12 11:12:06

Some 67 children die of pneumonia in Bangladesh. This disease kills around 24,300 children every year in the country. Around 18 per cent of children in Bangladesh die from pneumonia every year before...

Russia’s Sputnik V COVID-19 vaccine ‘92pc effective’

Russia’s Sputnik V COVID-19 vaccine ‘92pc effective’

-- 2020-11-11 16:39:47

Russia's Sputnik V vaccine is 92 per cent effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to ke...

One in five COVID-19 patients develop mental illness within 90 days

One in five COVID-19 patients develop mental illness within 90 days

-- 2020-11-10 18:58:29

Many COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20 per cent of those infected with the coronavirus are di...

TIB finds corruption, irregularities in heath sector

TIB finds corruption, irregularities in heath sector

FE ONLINE REPORT 2020-11-10 17:44:17

A latest study found corruption and irregularities in the health sector in the preparation, planning, and rapid response to stem the Covid-19 pandemic. The study conducted by Transparency Internation...

11 digital women’s health centres launched

11 digital women’s health centres launched

FE ONLINE REPORT 2020-11-09 19:06:01

More than half a million female borrowers of small loans and community people will be provided with medical advice digitally free of cost in view of the pandemic-induced health risks in the winter. D...

Global coronavirus cases surpass 50 million after 30-day spike

Global coronavirus cases surpass 50 million after 30-day spike

Reuters 2020-11-08 20:23:03

Global coronavirus infections exceeded 50 million on Sunday, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total. October was the w...

Where are we in the coronavirus vaccine race?

Where are we in the coronavirus vaccine race?

REUTERS 2020-11-07 14:07:31

Drugmakers and research centres around the world are working on Covid-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. Some...

Cornea appears to resist infection from coronavirus: study

Cornea appears to resist infection from coronavirus: study

Xinhua 2020-11-05 17:06:23

A study by researchers at Washington University School of Medicine in St. Louis suggests the eye's cornea can resist infection from the novel coronavirus. Prior research in human and mouse corneal ti...